KILITCH DRUGS Fact Sheet, KILITCH DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KILITCH DRUGS Fact Sheet    (KHDG)


EV Stocks: Which is Tanushree's Top Pick?


Here is the latest financial fact sheet of KILITCH DRUGS. For more details, see the KILITCH DRUGS quarterly results and KILITCH DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

KILITCH DRUGS Price History

Price Rs 237.7
Mkt Cap Rs m 3,704
Vol '000 5.9
P/E X 59.8
P/CF X 64.4
EPS (TTM) Rs 4.0
1 Day % 3.2
No. of shares m 15.58
1 Week % -5.9
1 Month % 19.9
1 Year % 164.1
52 week H/L Rs 276.4/79.4
As on Jan 25, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

KILITCH DRUGS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
KILITCH DRUGS EQUITY SHARE DATA
High Rs59135242217139 
Low Rs3145776378 
Sales per share (Unadj.) Rs21.737.253.734.644.2 
Earnings per share (Unadj.) Rs-6.73.82.50.52.4 
Diluted earnings per shareRs-5.73.32.50.52.4 
Cash flow per share (Unadj.) Rs0.75.23.81.83.7 
Dividends per share (Unadj.) Rs00.500.5000 
Adj. dividends per shareRs0.000.440.490.000.00 
Avg Dividend yield %00.60.300 
Book value per share (Unadj.) Rs75.478.978.175.981.8 
Adj. book value per shareRs64.169.577.075.181.4 
Shares outstanding (eoy) m13.2313.7315.3615.4315.49 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.12.43.04.12.5 
Avg P/E ratio x-6.724.064.0257.044.6 
P/CF ratio (eoy) x69.017.241.776.229.2 
Price / Book Value ratio x0.61.12.01.81.3 
Dividend payout %013.320.000 
Avg Mkt Cap Rs m5971,2342,4522,1641,679 
No. of employees `000NANANANANA 
Total wages/salary Rs m3443535752 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
KILITCH DRUGS INCOME DATA
Net Sales Rs m287510825533685 
Other income Rs m1133534627 
Total revenues Rs m298543878579712 
Gross profit Rs m-55360053 
Depreciation Rs m9820212020 
Interest Rs m24699 
Profit before tax Rs m-9361861651 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m-41048814 
Profit after tax Rs m-895238838 
Gross profit margin %-1.910.47.307.8 
Effective tax rate %4.615.755.447.626.4 
Net profit margin %-31.010.14.61.65.5 
KILITCH DRUGS BALANCE SHEET DATA
Current assets Rs m486630649558804 
Current liabilities Rs m117149201220733 
Net working cap to sales %128.794.254.363.410.3 
Current ratio x4.24.23.22.51.1 
Inventory Days Days687410238361333 
Debtors Days Days186148861,0861,221 
Net fixed assets Rs m6196317778611,215 
Share capital Rs m132137154154155 
"Free" reserves Rs m8669461,0461,0161,113 
Net worth Rs m9981,0831,1991,1711,268 
Long term debt Rs m00000 
Total assets Rs m1,1041,2611,4261,4192,019 
Interest coverage x-59.115.714.32.76.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.30.40.60.40.3 
Return on assets %-7.94.43.11.32.3 
Return on equity %-8.94.83.20.73.0 
Return on capital %-9.26.07.72.24.7 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m172358797391189 
Fx outflow Rs m2144695149 
Net fx Rs m151314729340141 
KILITCH DRUGS CASH FLOW
From Operations Rs m 11 14 3 45 457 
From Investments Rs m -15 -45 -140 -105 -376 
From Financial Activity Rs m 0 55 169 9 16 
Net Cashflow Rs m -5 25 32 -51 97 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 68.3%
Institution 0.0%
Non-Institution 31.7%
Total 100.0%
Free Float 31.8%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off C 301/2 M I D C, T T C Industrial Area, Pawane Village, Navi Mumbai - 400705
E-mail info@kilitch.com Web https://kilitch.com
Tel 022-6299 6300 Fax 022-2768 0912
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1992 BSE CODE: 524500 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare KILITCH DRUGS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK KILITCH DRUGS

  • Track your investment in KILITCH DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KILITCH DRUGS

KILITCH DRUGS - MYLAN COMPARISON

COMPARE KILITCH DRUGS WITH

MARKET STATS